Ibuprofen Market: By Indication (Fever, Inflammation, Pain), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and others, and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Ibuprofen Market size was valued at USD 6832 Mn in 2023 and poised to grow at a significant CAGR 7.6% from 2024-2030. Rising adoption of an intravenous drug delivery mode for acute pain management owing to faster commencement of action as associated with the additional routes (oral and transdermal mode of administration) as well as the targeted property of drug delivery. IV Ibuprofen progresses the management in pain through less dependency on opioid painkilling medicine, which may lead to numerous complications of health including sedation, dizziness, and others. Caldolor (Cumberland Pharmaceuticals) is predominantly an injectable Ibuprofen drug accessible in the market; henceforth, it partakes enormous demand with slight competition. However, prolonged processes for approval coupled with restricted approvals in certain countries are projected to restraint the market growth. Key players in the global Ibuprofen market enhance their product portfolio and consumer base by adopting striking market strategies like collaborations, acquisitions, and technological innovations, among others. For instance, on Feb 04, 2015- Harbin Gloria Pharma will pay a considerable amount to acquire a maximum stake in Shanxi Powerdone, which makes chemical drugs and compound preparations.

This report gives a comprehensive outlook on Ibuprofen across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa. This report gives historical, current, and future market sizes (US$ Mn) based on application, formula type, and regions. This report studies global Ibuprofen market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the global Ibuprofen market report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed global Ibuprofen market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global Ibuprofen market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global Ibuprofen products.

Global Ibuprofen Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.6%

Largest Market

North America

Fastest Growing Market

Europe
Ibuprofen Market Dynamics

Ibuprofen are predominantly used for various health complications such as pain, fever, inflammation, others. Treatment of inflammation with the aid of Ibuprofen is one of the major applications. Ibuprofen is generally used besides most often recommended NSAID.2,3 It is a non-selective inhibitor of cyclo-oxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2).4 Though its anti-inflammatory properties might be weaker as compared to the other NSAIDs, it devours a conspicuous analgesic and antipyretic role. Its effects are in arrears to the inhibitory actions on cyclo-oxygenases, which are involved in the synthesis of prostaglandins. Prostaglandins have a significant part in the production of fever, pain, inflammation.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Ibuprofen Market Segmentation

By Indication
  • Fever
  • Inflammation
  • Pain
By Route of Administration
  • Oral
  • Parenteral 
By Distribution Channel
  • Hospital Pharmacies,
  • Retail Pharmacies,
  • Online Pharmacies
  • others

Frequently Asked Questions

The ibuprofen market size was valued at USD 6832 million in 2023  

Cumberland Pharmaceuticals Inc, Alveda Pharmaceuticals, Inc. (Acquired by Teligent, Inc.), CSL Limited, Sandor Medicaids Pvt. Ltd., Soho Industri Pharmasi, Germin MED

North America is the fastest-growing region for ibuprofen market

1. Executive Summary
2.  Ibuprofen Market Introduction 
2.1.Global Ibuprofen Market  - Taxonomy
2.2.Global Ibuprofen Market  - Definitions
2.2.1.Indication
2.2.2.Route of Administration
2.2.3.Distribution Channel 
2.2.4.Region
3. Global Ibuprofen Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Ibuprofen Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Ibuprofen Market  By Indication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Fever
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Inflammation
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Pain
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Ibuprofen Market  By Route of Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Oral
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Parenteral 
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7. Global Ibuprofen Market  By Distribution Channel , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospital Pharmacies,
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies,
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacies
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. others
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Global Ibuprofen Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Ibuprofen Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Fever
9.1.2.Inflammation
9.1.3.Pain
9.2.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Oral
9.2.2.Parenteral 
9.3.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacies,
9.3.2.Retail Pharmacies,
9.3.3.Online Pharmacies
9.3.4.others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Ibuprofen Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Indication Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Fever
10.1.2.Inflammation
10.1.3.Pain
10.2.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral
10.2.2.Parenteral 
10.3.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies,
10.3.2.Retail Pharmacies,
10.3.3.Online Pharmacies
10.3.4.others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Ibuprofen Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Indication Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Fever
11.1.2.Inflammation
11.1.3.Pain
11.2.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral
11.2.2.Parenteral 
11.3.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies,
11.3.2.Retail Pharmacies,
11.3.3.Online Pharmacies
11.3.4.others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Ibuprofen Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Indication Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Fever
12.1.2.Inflammation
12.1.3.Pain
12.2.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral
12.2.2.Parenteral 
12.3.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies,
12.3.2.Retail Pharmacies,
12.3.3.Online Pharmacies
12.3.4.others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Ibuprofen Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Indication Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Fever
13.1.2.Inflammation
13.1.3.Pain
13.2.  Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral
13.2.2.Parenteral 
13.3.  Distribution Channel  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies,
13.3.2.Retail Pharmacies,
13.3.3.Online Pharmacies
13.3.4.others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M&A, Strategies, and SWOT Analysis) 
14.2.1.Cumberland Pharmaceuticals Inc.
14.2.2.Alveda Pharmaceuticals, Inc. (Acquired by Teligent, Inc.)
14.2.3.CSL Limited
14.2.4 Sandor Medicaids Pvt. Ltd.
14.2.5.Soho Industri Pharmasi
14.2.6.Germin MED
14.2.7.Grifols S.A.
14.2.8.Harbin Gloria Pharmaceuticals Co., Ltd.
14.2.9.Al Nabeel International Ltd
14.2.10.Laboratorios Valmorca, C.A
15. Research Methodology 
16. Appendix and Abbreviations 
  • Cumberland Pharmaceuticals Inc.
  • Alveda Pharmaceuticals, Inc. (Acquired by Teligent, Inc.)
  • CSL Limited
  • Sandor Medicaids Pvt. Ltd.
  • Soho Industri Pharmasi
  • Germin MED
  • Grifols S.A.
  • Harbin Gloria Pharmaceuticals Co., Ltd.
  • Al Nabeel International Ltd
  • Laboratorios Valmorca, C.A

Adjacent Markets